Carotid Angioplasty and Stenting (CAS) has recently emerged as a popular alternative to endarterectomy for the treatment of carotid atherosclerosis. The recent approval, by the FDA, of carotid artery stents has initiated a global market in those devices.
Guidant, Boston Scientific, Abbott, Medtronic and J&J have all entered the market; however, this space still lends itself also to MedTech start-ups with innovative devices especially in the embolic protection niche.
'Carotid Stents - Market & Technology Forecast report' gives an overview of the state of both the technology and the market. It profiles the current market landscape for carotid stents and explores the market potential for those devices with global forecasts until 2010.
The report details many pressing issues in the carotid stenting space including the number of equipped centers and trained specialists in Europe and the US. It also profiles current approved devices and the status of clinical development of potential new entrants.
Report Highlights:
- Current State of the Science for both carotid endarterectomy (CEA) and carotid angioplasty and stenting (CAS).
- Recent clinical trials and their findings.
- Epidemiology of stroke, carotid stenosis and estimated number of carotid artery stenting procedures.
- Current market for carotid artery stents segmented geographically. - Potential market for cartoid artery stents.
- Leading players in the cartotid artery stenting space and potential new entrants.
- Market forecasts till 2010.
Carotid Stents: Market & Technology Forecast report offers a short but thorough analysis of the potential for a global market for carotid artery stents. It is targeted at busy executives scanning for windows of opportunities opening in the interventional cardiology and neuroradiology spaces.
